August 19, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced that Isabel Struik has joined the team as VP Sales & Marketing. Isabel holds a degree in toxicological sciences of the University of Wageningen, The Netherlands. She has been working in contract research for over 23 years, mostly in the field of clinical trials and central laboratory services for European and US-based companies. “We are very happy to welcome Isabel to our team and are convinced that Isabel will leverage her experience in clinical trials to the benefit of our customers and our company. Especially after the recent acquisition of our US based laboratory in Memphis, we are eager to further expand our sales and marketing activities. We want to keep the momentum with globally active biotech and pharma customers that need central lab services for their clinical development programmes, to develop medicines to save and improve lives across the globe.” said Stephan Wnendt, CEO of MLM.
“I am delighted to join MLM at these exciting times for the company, I see a vast potential for future growth based due to the high flexibility of MLM, its quality standards that exceeds customer expectation, its broad analytical capabilities and innovative solutions in kit building and customer friendly digitalsolutions” added Isabel Struik. “Therefore, I am thrilled to be a part of MLM’s success story going forward. The current pandemic has clearly shown the importance of clinical trials for medical innovation. MLM has been on the forefront of clinical research as being involved as central lab for COVID-19 vaccination trials.”
Isabel will be located in MLM’s German 38,000 sq ft facility in Moenchengladbach, close to Duesseldorf, Germany. Isabel Struik can be reached under istruik(at)mlm-labs(dot)com or +49 2161 46 42 108.